Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2021

RGX-314 for Wet AMD: Phase 1/2a Results

Lejla Vajzovic, MD

Show Description +

Lejla Vajzovic, MD, shares promising data on subretinal delivery of RGX-314 gene therapy for wet AMD patients, particularly for higher dose cohorts.

Posted: 10/21/2021

Keywords:

Clinical Trials

•

Wet AMD

•

retina-meeting-recap

Up Next

Questions Remain for Pneumatic Vitreolysis for VMT

Questions Remain for Pneumatic Vitreolysis for VMT

Calvin Mein, MD; and Clement Chan, MD

Universal Face Mask Use and Endophthalmitis Risk

Universal Face Mask Use and Endophthalmitis Risk

Sunir Garg, MD

The Path to a Dry Retina in VIVID/VISTA

The Path to a Dry Retina in VIVID/VISTA

Rishi P. Singh, MD

The Latest Phase 3 Data on Faricimab for DME

The Latest Phase 3 Data on Faricimab for DME

Caroline R. Baumal, MD

Novel Sustained-Release Therapies for ME Due to RVO

Novel Sustained-Release Therapies for ME Due to RVO

Michael Singer, MD

Tackling Macular Edema with Suprachoroidal CLS-TA

Tackling Macular Edema with Suprachoroidal CLS-TA

Steven Yeh, MD

Efficacy of Pegcetacoplan in GA: Fellow Eye Comparison

Efficacy of Pegcetacoplan in GA: Fellow Eye Comparison

Nathan Steinle, MD

Slowing GA Growth with C5 Inhibition

Slowing GA Growth with C5 Inhibition

Jason Hsu, MD

Pearls for Preserving the Conjunctiva and Tenon’s Capsule With PDS Implantation

Pearls for Preserving the Conjunctiva and Tenon’s Capsule With PDS Implantation

Veeral Sheth, MD

A Look at Fluid in Wet AMD Patients With the Port Delivery System

A Look at Fluid in Wet AMD Patients With the Port Delivery System

Arshad Khanani, MD

The Benefits of PPV for Visually Significant Floaters

The Benefits of PPV for Visually Significant Floaters

Matthew Cunningham, MD

Back to All Videos

RGX-314 for Wet AMD: Phase 1/2a Results

Lejla Vajzovic, MD

Lejla Vajzovic, MD, shares promising data on subretinal delivery of RGX-314 gene therapy for wet AMD patients, particularly for higher dose cohorts.

Posted: 10/21/2021

Keywords:

Clinical Trials

•

Wet AMD

•

retina-meeting-recap

Please log in to leave a comment.

More From ASRS: 2021 Coverage

Efficacy of Pegcetacoplan in GA: Fellow Eye Comparison

Efficacy of Pegcetacoplan in GA: Fellow Eye Comparison

Nathan Steinle, MD

Slowing GA Growth with C5 Inhibition

Slowing GA Growth with C5 Inhibition

Jason Hsu, MD

Pearls for Preserving the Conjunctiva and Tenon’s Capsule With PDS Implantation

Pearls for Preserving the Conjunctiva and Tenon’s Capsule With PDS Implantation

Veeral Sheth, MD

A Look at Fluid in Wet AMD Patients With the Port Delivery System

A Look at Fluid in Wet AMD Patients With the Port Delivery System

Arshad Khanani, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2021.